Treatment Response Rates for Hepatitis B in Pakistan
Author Information
Author(s): Ali Liaqat, Idrees Muhammad, Ali Muhammad, Rehman Irshad-ur, Hussain Abrar, Afzal Samia, Butt Sadia, Saleem Sana, Munir Saira, Badar Sadaf
Primary Institution: Division of Molecular Virology, National Centre of Excellence in Molecular Biology, University of the Punjab
Hypothesis
What are the treatment response rates to various anti-viral drugs in Pakistani Hepatitis B Virus infected patients?
Conclusion
Interferon-α is the most effective therapy for Hepatitis B infection in the Pakistani population, with a treatment response rate of up to 47.95%.
Supporting Evidence
- The average treatment response of Lamivudine is 25.81%.
- The average treatment response of interferon-α is 47.95%.
- Peg-Interferon was shown to be ineffective against HBV/HCV/HDV co-infection.
- Genotype C & D are the most common HBV genotypes in Pakistan.
Takeaway
This study shows that interferon-α works best for treating Hepatitis B in Pakistan, but some types of the virus are harder to treat.
Methodology
The article reviews existing literature on treatment responses to HBV therapies in the Pakistani population.
Limitations
Limited studies on HBV treatment response in the Pakistani population.
Participant Demographics
The study focuses on the Pakistani population with Hepatitis B.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website